Drug
Rabeprazole
Rabeprazole: highest development phase Phase 3, developed by Eisai. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| rabeprazole sodium NCT00236197 | Phase 3 | Heartburn |
| Rabeprazole NCT01398410 | Phase 2/3 | Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin |
Latest
No recent events.
Follow Rabeprazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.